Jingyan Xue

1.1k total citations
34 papers, 739 citations indexed

About

Jingyan Xue is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Jingyan Xue has authored 34 papers receiving a total of 739 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Cancer Research, 20 papers in Molecular Biology and 9 papers in Oncology. Recurrent topics in Jingyan Xue's work include Cancer-related molecular mechanisms research (10 papers), RNA modifications and cancer (7 papers) and Breast Cancer Treatment Studies (6 papers). Jingyan Xue is often cited by papers focused on Cancer-related molecular mechanisms research (10 papers), RNA modifications and cancer (7 papers) and Breast Cancer Treatment Studies (6 papers). Jingyan Xue collaborates with scholars based in China, United States and Switzerland. Jingyan Xue's co-authors include Jiong Wu, Yayun Chi, Zhao‐Hui Wu, Bingqiu Xiu, Weiru Chi, Rong Guo, Jiajian Chen, Naisi Huang, Jing Si and Shenglin Huang and has published in prestigious journals such as Nature Communications, The EMBO Journal and Cancer.

In The Last Decade

Jingyan Xue

31 papers receiving 736 citations

Peers

Jingyan Xue
Pingqing Tan China
Yanmei Cui China
Qingfeng Ni China
Bingjian Lü China
Lehang Lin China
Yingqiu Y. Liu United States
Gongmin Zhu China
Dat Nguyen United States
Bangrong Cao China
Pingqing Tan China
Jingyan Xue
Citations per year, relative to Jingyan Xue Jingyan Xue (= 1×) peers Pingqing Tan

Countries citing papers authored by Jingyan Xue

Since Specialization
Citations

This map shows the geographic impact of Jingyan Xue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingyan Xue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingyan Xue more than expected).

Fields of papers citing papers by Jingyan Xue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jingyan Xue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingyan Xue. The network helps show where Jingyan Xue may publish in the future.

Co-authorship network of co-authors of Jingyan Xue

This figure shows the co-authorship network connecting the top 25 collaborators of Jingyan Xue. A scholar is included among the top collaborators of Jingyan Xue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jingyan Xue. Jingyan Xue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Jiarui, Run‐Wu Zhang, Jingyan Xue, et al.. (2025). Synergistic enhancement of alkaloid biosynthesis in Catharanthus roseus CMCs via enzyme Inhibition and abiotic elicitation. Plant Cell Tissue and Organ Culture (PCTOC). 162(3).
2.
Chi, Weiru, Bingqiu Xiu, Qi Zhang, et al.. (2025). PPARG Activation of Fatty Acid Metabolism Drives Resistance to Anti-HER2 Therapies in HER2-Positive Breast Cancer. International Journal of Biological Sciences. 21(6). 2396–2414. 3 indexed citations
3.
4.
Chi, Weiru, Yuwei Ma, Qí Zhāng, et al.. (2024). DUSP4 enhances therapeutic sensitivity in HER2-positive breast cancer by inhibiting the G6PD pathway and ROS metabolism by interacting with ALDOB. Translational Oncology. 46. 102016–102016. 3 indexed citations
5.
Chi, Weiru, Bingqiu Xiu, Pei Li, et al.. (2023). MNX1 Promotes Anti-HER2 Therapy Sensitivity via Transcriptional Regulation of CD-M6PR in HER2-Positive Breast Cancer. International Journal of Molecular Sciences. 25(1). 221–221. 2 indexed citations
6.
Si, Jing, Rong Guo, Bingqiu Xiu, et al.. (2022). Stabilization of CCDC102B by Loss of RACK1 Through the CMA Pathway Promotes Breast Cancer Metastasis via Activation of the NF-κB Pathway. Frontiers in Oncology. 12. 927358–927358. 8 indexed citations
7.
Li, Pei, Bingqiu Xiu, Li-Yi Zhang, et al.. (2022). The Prognoses of Young Women With Breast Cancer (≤35 years) With Different Surgical Options: A Propensity Score Matching Retrospective Cohort Study. Frontiers in Oncology. 12. 795023–795023. 8 indexed citations
8.
Ye, Fangdie, Min Xiong, Bingqiu Xiu, et al.. (2022). Cross-talk of four types of RNA modification proteins with adenosine reveals the landscape of multivariate prognostic patterns in breast cancer. Frontiers in Genetics. 13. 943378–943378. 3 indexed citations
9.
Xue, Jingyan, Xiaoning Xie, & Xiaodong Liu. (2022). Differing responses of precipitation in Northern Hemisphere mid-latitudes to increased black carbon aerosols and carbon dioxide. Environmental Research. 210. 112938–112938. 2 indexed citations
10.
Li, Pei, et al.. (2021). Development and Validation of a Robust Ferroptosis-Related Gene Panel for Breast Cancer Disease-Specific Survival. Frontiers in Cell and Developmental Biology. 9. 709180–709180. 8 indexed citations
11.
Xue, Jingyan, Sheng Huang, Jiaying Chen, et al.. (2021). Overexpression of Long Non-Coding RNA Linc01315 Predicts Poor Prognosis in Breast Cancer. Frontiers in Oncology. 11. 562378–562378. 4 indexed citations
12.
13.
Chi, Yayun, Jingyan Xue, Sheng Huang, et al.. (2019). CapG promotes resistance to paclitaxel in breast cancer through transactivation of PIK3R1/P50. Theranostics. 9(23). 6840–6855. 42 indexed citations
14.
Huang, Sheng, Yayun Chi, Weiru Chi, et al.. (2019). LINC00309 is associated with short disease-free survival in breast cancer. Cancer Cell International. 19(1). 210–210. 3 indexed citations
15.
Xue, Jingyan, Yan Xi, Rongbiao Tang, et al.. (2019). Evaluating the effect of Avastin on breast cancer angiogenesis using synchrotron radiation. Quantitative Imaging in Medicine and Surgery. 9(3). 418–426. 12 indexed citations
16.
Xiu, Bingqiu, Yayun Chi, Lei Liu, et al.. (2019). LINC02273 drives breast cancer metastasis by epigenetically increasing AGR2 transcription. Molecular Cancer. 18(1). 187–187. 169 indexed citations
17.
Guo, Liang, et al.. (2017). Phosphorylated eIF2α predicts disease-free survival in triple-negative breast cancer patients. Scientific Reports. 7(1). 44674–44674. 35 indexed citations
18.
Xue, Jingyan. (2014). MicroRNAs in cancer therapeutic response: Friend and foe. World Journal of Clinical Oncology. 5(4). 730–730. 43 indexed citations
19.
Niu, Jixiao, Yuling Shi, Jingyan Xue, et al.. (2013). USP10 inhibits genotoxic NF‐κB activation by MCPIP1‐facilitated deubiquitination of NEMO. The EMBO Journal. 32(24). 3206–3219. 89 indexed citations
20.
Fei, Fei, Canming Chen, Jingyan Xue, et al.. (2012). Efficacy and Safety of Docetaxel Combined With Oxaliplatin as a Neoadjuvant Chemotherapy Regimen for Chinese Triple-Negative Local Advanced Breast Cancer Patients. American Journal of Clinical Oncology. 36(6). 545–551. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pingqing Tan Breakdown of academic impact, for papers by Yanmei Cui Breakdown of academic impact, for papers by Qingfeng Ni Breakdown of academic impact, for papers by Bingjian Lü Breakdown of academic impact, for papers by Lehang Lin Breakdown of academic impact, for papers by Yingqiu Y. Liu Breakdown of academic impact, for papers by Gongmin Zhu Breakdown of academic impact, for papers by Dat Nguyen Breakdown of academic impact, for papers by Bangrong Cao
Rankless by CCL
2026